✦ LIBER ✦

Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration

✍ Scribed by Jeanette Seidel; Klaudia Kunc; Kurt Possinger; Christian Jehn; Diana Lüftner

Book ID: 116302384
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 828 KB
Volume: 414
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2011.09.062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P192 CUB-domain containing protein (CDCP

P192 CUB-domain containing protein (CDCP1)-mediated anchorage free survival and migratory properties in breast cancer cell lines are not affected by tyrosine kinase inhibitor lapatinib

✍ J. Seidel; K. Kunc; K. Possinger; D.I. Lüftner 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Effects of tyrosine kinase inhibitors on

Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the RAS signaling pathway

✍ Jeffrey W. Clark; Anabela Santos-Moore; Lisa E. Stevenson; A. Raymond Frackelton 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 698 KB

Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr